Diversify Advisory Services’s AbbVie ABBV Stock Holding History

Diversify Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$257	Buy	+100	New	+$21.5K	﹤0.01%	1268

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Diversify Advisory Services's ABBV Position: Q2 2026 in Review

Diversify Advisory Services increased its AbbVie (ABBV) stake by 1,423% in Q2 2026, buying an estimated $13M and bringing the position to 64,821 shares worth $16.7M. The position accounts for 0.28% of the portfolio, ranked #72.

Diversify Advisory Services first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Diversify Advisory Services held 64,821 shares of AbbVie worth $16.7M as of Q2 2026.
Diversify Advisory Services bought 60,566 AbbVie shares in Q2 2026, an estimated $13M.
AbbVie made up 0.28% of Diversify Advisory Services's portfolio in Q2 2026, its #72 holding.
Diversify Advisory Services first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.